UniProt ID | HP1B3_HUMAN | |
---|---|---|
UniProt AC | Q5SSJ5 | |
Protein Name | Heterochromatin protein 1-binding protein 3 | |
Gene Name | HP1BP3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 553 | |
Subcellular Localization | Nucleus . Chromosome . localized in nuclei but not in nucleoli in interphase. Colocalized with chromosomes in mitosis, with a gradually increased during G1 progression and a maximum level during late G1 phase (G1/S). | |
Protein Description | Component of heterochromatin that maintains heterochromatin integrity during G1/S progression and regulates the duration of G1 phase to critically influence cell proliferative capacity. [PubMed: 24830416). Mediates chromatin condensation during hypoxia] | |
Protein Sequence | MATDTSQGELVHPKALPLIVGAQLIHADKLGEKVEDSTMPIRRTVNSTRETPPKSKLAEGEEEKPEPDISSEESVSTVEEQENETPPATSSEAEQPKGEPENEEKEENKSSEETKKDEKDQSKEKEKKVKKTIPSWATLSASQLARAQKQTPMASSPRPKMDAILTEAIKACFQKSGASVVAIRKYIIHKYPSLELERRGYLLKQALKRELNRGVIKQVKGKGASGSFVVVQKSRKTPQKSRNRKNRSSAVDPEPQVKLEDVLPLAFTRLCEPKEASYSLIRKYVSQYYPKLRVDIRPQLLKNALQRAVERGQLEQITGKGASGTFQLKKSGEKPLLGGSLMEYAILSAIAAMNEPKTCSTTALKKYVLENHPGTNSNYQMHLLKKTLQKCEKNGWMEQISGKGFSGTFQLCFPYYPSPGVLFPKKEPDDSRDEDEDEDESSEEDSEDEEPPPKRRLQKKTPAKSPGKAASVKQRGSKPAPKVSAAQRGKARPLPKKAPPKAKTPAKKTRPSSTVIKKPSGGSSKKPATSARKEVKLPGKGKSTMKKSFRVKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATDTSQGE ------CCCCCCCCC | 17.74 | 20068231 | |
3 | Phosphorylation | -----MATDTSQGEL -----CCCCCCCCCC | 38.21 | 22167270 | |
5 | Phosphorylation | ---MATDTSQGELVH ---CCCCCCCCCCCC | 20.70 | 29255136 | |
6 | Phosphorylation | --MATDTSQGELVHP --CCCCCCCCCCCCC | 38.71 | 23401153 | |
9 (in isoform 2) | Phosphorylation | - | 39.73 | 29116813 | |
13 (in isoform 2) | Phosphorylation | - | 19.01 | 29116813 | |
14 | Ubiquitination | QGELVHPKALPLIVG CCCCCCCCHHHHEEE | 47.91 | 21890473 | |
14 (in isoform 1) | Ubiquitination | - | 47.91 | 21890473 | |
14 (in isoform 5) | Ubiquitination | - | 47.91 | 21890473 | |
29 | 2-Hydroxyisobutyrylation | AQLIHADKLGEKVED EEEEEHHHHCCCCCC | 60.21 | - | |
29 | Acetylation | AQLIHADKLGEKVED EEEEEHHHHCCCCCC | 60.21 | 23749302 | |
29 | Ubiquitination | AQLIHADKLGEKVED EEEEEHHHHCCCCCC | 60.21 | 33845483 | |
33 | Ubiquitination | HADKLGEKVEDSTMP EHHHHCCCCCCCCCC | 49.48 | 33845483 | |
37 | Phosphorylation | LGEKVEDSTMPIRRT HCCCCCCCCCCCCCC | 17.07 | 26074081 | |
38 | Phosphorylation | GEKVEDSTMPIRRTV CCCCCCCCCCCCCCC | 39.01 | 26074081 | |
39 | Sulfoxidation | EKVEDSTMPIRRTVN CCCCCCCCCCCCCCC | 2.77 | 21406390 | |
44 | Phosphorylation | STMPIRRTVNSTRET CCCCCCCCCCCCCCC | 17.75 | 26055452 | |
47 | Phosphorylation | PIRRTVNSTRETPPK CCCCCCCCCCCCCCH | 25.22 | 23401153 | |
48 | Phosphorylation | IRRTVNSTRETPPKS CCCCCCCCCCCCCHH | 27.59 | 23401153 | |
51 | Phosphorylation | TVNSTRETPPKSKLA CCCCCCCCCCHHHCC | 41.42 | 25159151 | |
55 | Phosphorylation | TRETPPKSKLAEGEE CCCCCCHHHCCCCCC | 38.38 | 23403867 | |
64 | Sumoylation | LAEGEEEKPEPDISS CCCCCCCCCCCCCCC | 58.94 | 28112733 | |
70 | Phosphorylation | EKPEPDISSEESVST CCCCCCCCCCHHCCC | 38.79 | 30278072 | |
71 | Phosphorylation | KPEPDISSEESVSTV CCCCCCCCCHHCCCH | 45.80 | 30278072 | |
74 | Phosphorylation | PDISSEESVSTVEEQ CCCCCCHHCCCHHHH | 19.81 | 30278072 | |
76 | Phosphorylation | ISSEESVSTVEEQEN CCCCHHCCCHHHHCC | 35.69 | 30278072 | |
77 | Phosphorylation | SSEESVSTVEEQENE CCCHHCCCHHHHCCC | 29.76 | 30278072 | |
85 | Phosphorylation | VEEQENETPPATSSE HHHHCCCCCCCCCCC | 46.27 | 30278072 | |
89 | Phosphorylation | ENETPPATSSEAEQP CCCCCCCCCCCCCCC | 38.26 | 30576142 | |
89 | Ubiquitination | ENETPPATSSEAEQP CCCCCCCCCCCCCCC | 38.26 | 22817900 | |
90 | Phosphorylation | NETPPATSSEAEQPK CCCCCCCCCCCCCCC | 28.43 | 25850435 | |
90 | Ubiquitination | NETPPATSSEAEQPK CCCCCCCCCCCCCCC | 28.43 | 22817900 | |
91 | Phosphorylation | ETPPATSSEAEQPKG CCCCCCCCCCCCCCC | 36.15 | 30576142 | |
92 | Ubiquitination | TPPATSSEAEQPKGE CCCCCCCCCCCCCCC | 56.86 | 22817900 | |
93 | Ubiquitination | PPATSSEAEQPKGEP CCCCCCCCCCCCCCC | 23.75 | 21890473 | |
93 (in isoform 2) | Ubiquitination | - | 23.75 | 21890473 | |
97 | Sumoylation | SSEAEQPKGEPENEE CCCCCCCCCCCCCHH | 75.50 | 28112733 | |
110 | Phosphorylation | EEKEENKSSEETKKD HHHHHCCCHHHHHHH | 55.34 | 26657352 | |
111 | Phosphorylation | EKEENKSSEETKKDE HHHHCCCHHHHHHHH | 40.85 | 29255136 | |
111 | Ubiquitination | EKEENKSSEETKKDE HHHHCCCHHHHHHHH | 40.85 | 24816145 | |
114 | Phosphorylation | ENKSSEETKKDEKDQ HCCCHHHHHHHHHHH | 39.07 | 23927012 | |
121 (in isoform 5) | Phosphorylation | - | 68.42 | 28634120 | |
127 | Ubiquitination | DQSKEKEKKVKKTIP HHHHHHHHHHHHHHC | 74.14 | 22817900 | |
128 | Ubiquitination | QSKEKEKKVKKTIPS HHHHHHHHHHHHHCH | 61.45 | 22817900 | |
130 | Ubiquitination | KEKEKKVKKTIPSWA HHHHHHHHHHHCHHH | 53.75 | 22817900 | |
131 | Ubiquitination | EKEKKVKKTIPSWAT HHHHHHHHHHCHHHH | 55.46 | 21890473 | |
131 (in isoform 1) | Ubiquitination | - | 55.46 | 21890473 | |
132 | Phosphorylation | KEKKVKKTIPSWATL HHHHHHHHHCHHHHC | 32.19 | 19060867 | |
132 | Ubiquitination | KEKKVKKTIPSWATL HHHHHHHHHCHHHHC | 32.19 | 32015554 | |
135 | Phosphorylation | KVKKTIPSWATLSAS HHHHHHCHHHHCCHH | 26.03 | 22199227 | |
138 | Phosphorylation | KTIPSWATLSASQLA HHHCHHHHCCHHHHH | 18.26 | 26657352 | |
139 (in isoform 3) | Ubiquitination | - | 2.88 | 21890473 | |
140 | Phosphorylation | IPSWATLSASQLARA HCHHHHCCHHHHHHH | 22.86 | 25159151 | |
142 | Phosphorylation | SWATLSASQLARAQK HHHHCCHHHHHHHHH | 23.50 | 17525332 | |
146 | Methylation | LSASQLARAQKQTPM CCHHHHHHHHHHCCC | 46.25 | 115386917 | |
149 | Ubiquitination | SQLARAQKQTPMASS HHHHHHHHHCCCCCC | 55.97 | 24816145 | |
151 | Phosphorylation | LARAQKQTPMASSPR HHHHHHHCCCCCCCC | 23.28 | 23927012 | |
155 | Phosphorylation | QKQTPMASSPRPKMD HHHCCCCCCCCHHHH | 34.32 | 30266825 | |
156 | Phosphorylation | KQTPMASSPRPKMDA HHCCCCCCCCHHHHH | 18.52 | 29255136 | |
160 | Acetylation | MASSPRPKMDAILTE CCCCCCHHHHHHHHH | 51.17 | 25953088 | |
160 | Ubiquitination | MASSPRPKMDAILTE CCCCCCHHHHHHHHH | 51.17 | 29967540 | |
166 | Phosphorylation | PKMDAILTEAIKACF HHHHHHHHHHHHHHH | 19.77 | 26074081 | |
170 | Ubiquitination | AILTEAIKACFQKSG HHHHHHHHHHHHHCC | 46.26 | 32015554 | |
175 | Acetylation | AIKACFQKSGASVVA HHHHHHHHCCCEEEE | 30.52 | 26051181 | |
175 | Ubiquitination | AIKACFQKSGASVVA HHHHHHHHCCCEEEE | 30.52 | 29967540 | |
176 | Phosphorylation | IKACFQKSGASVVAI HHHHHHHCCCEEEEE | 28.89 | 19691289 | |
184 | Ubiquitination | GASVVAIRKYIIHKY CCEEEEEEHHHHHHC | 18.91 | 33845483 | |
190 | Acetylation | IRKYIIHKYPSLELE EEHHHHHHCCCHHHH | 48.74 | 25825284 | |
190 | Malonylation | IRKYIIHKYPSLELE EEHHHHHHCCCHHHH | 48.74 | 26320211 | |
190 | Ubiquitination | IRKYIIHKYPSLELE EEHHHHHHCCCHHHH | 48.74 | 19608861 | |
193 | Phosphorylation | YIIHKYPSLELERRG HHHHHCCCHHHHHHH | 31.24 | 25599653 | |
204 | Acetylation | ERRGYLLKQALKREL HHHHHHHHHHHHHHH | 30.81 | 27178108 | |
204 | Ubiquitination | ERRGYLLKQALKREL HHHHHHHHHHHHHHH | 30.81 | 29967540 | |
220 | Ubiquitination | RGVIKQVKGKGASGS HCCCHHHCCCCCCCC | 53.03 | 24816145 | |
222 | Ubiquitination | VIKQVKGKGASGSFV CCHHHCCCCCCCCEE | 45.65 | 33845483 | |
225 | Phosphorylation | QVKGKGASGSFVVVQ HHCCCCCCCCEEEEE | 43.57 | 20860994 | |
233 | Ubiquitination | GSFVVVQKSRKTPQK CCEEEEECCCCCCCC | 40.39 | 29967540 | |
236 | Ubiquitination | VVVQKSRKTPQKSRN EEEECCCCCCCCCCC | 72.19 | 24816145 | |
240 | Acetylation | KSRKTPQKSRNRKNR CCCCCCCCCCCCCCC | 53.22 | 12432513 | |
245 | Acetylation | PQKSRNRKNRSSAVD CCCCCCCCCCCCCCC | 61.33 | 12432527 | |
245 | Ubiquitination | PQKSRNRKNRSSAVD CCCCCCCCCCCCCCC | 61.33 | 33845483 | |
248 | Phosphorylation | SRNRKNRSSAVDPEP CCCCCCCCCCCCCCC | 31.85 | 23401153 | |
249 | Phosphorylation | RNRKNRSSAVDPEPQ CCCCCCCCCCCCCCC | 29.13 | 29255136 | |
253 | Ubiquitination | NRSSAVDPEPQVKLE CCCCCCCCCCCCCHH | 48.87 | 21890473 | |
253 (in isoform 2) | Ubiquitination | - | 48.87 | 21890473 | |
258 | Sumoylation | VDPEPQVKLEDVLPL CCCCCCCCHHHHHHH | 40.69 | 28112733 | |
258 | Ubiquitination | VDPEPQVKLEDVLPL CCCCCCCCHHHHHHH | 40.69 | 24816145 | |
274 | 2-Hydroxyisobutyrylation | FTRLCEPKEASYSLI HHHHCCCHHHHHHHH | 43.55 | - | |
274 | Acetylation | FTRLCEPKEASYSLI HHHHCCCHHHHHHHH | 43.55 | 26051181 | |
274 | Ubiquitination | FTRLCEPKEASYSLI HHHHCCCHHHHHHHH | 43.55 | 24816145 | |
277 | Phosphorylation | LCEPKEASYSLIRKY HCCCHHHHHHHHHHH | 19.15 | 28152594 | |
278 | Phosphorylation | CEPKEASYSLIRKYV CCCHHHHHHHHHHHH | 17.97 | 28152594 | |
279 | Phosphorylation | EPKEASYSLIRKYVS CCHHHHHHHHHHHHH | 18.15 | 28152594 | |
282 | Ubiquitination | EASYSLIRKYVSQYY HHHHHHHHHHHHHHC | 29.55 | 23000965 | |
283 | 2-Hydroxyisobutyrylation | ASYSLIRKYVSQYYP HHHHHHHHHHHHHCH | 42.90 | - | |
283 | Acetylation | ASYSLIRKYVSQYYP HHHHHHHHHHHHHCH | 42.90 | 26051181 | |
283 | Ubiquitination | ASYSLIRKYVSQYYP HHHHHHHHHHHHHCH | 42.90 | 33845483 | |
284 | Phosphorylation | SYSLIRKYVSQYYPK HHHHHHHHHHHHCHH | 8.76 | 28152594 | |
286 | Phosphorylation | SLIRKYVSQYYPKLR HHHHHHHHHHCHHHC | 14.91 | 28152594 | |
288 | Phosphorylation | IRKYVSQYYPKLRVD HHHHHHHHCHHHCCC | 17.77 | 28152594 | |
289 | Phosphorylation | RKYVSQYYPKLRVDI HHHHHHHCHHHCCCC | 6.05 | 28152594 | |
291 | Acetylation | YVSQYYPKLRVDIRP HHHHHCHHHCCCCHH | 32.57 | 26051181 | |
291 | Malonylation | YVSQYYPKLRVDIRP HHHHHCHHHCCCCHH | 32.57 | 32601280 | |
291 | Ubiquitination | YVSQYYPKLRVDIRP HHHHHCHHHCCCCHH | 32.57 | 22817900 | |
291 (in isoform 1) | Ubiquitination | - | 32.57 | 21890473 | |
302 | Acetylation | DIRPQLLKNALQRAV CCHHHHHHHHHHHHH | 49.09 | 25953088 | |
302 | Ubiquitination | DIRPQLLKNALQRAV CCHHHHHHHHHHHHH | 49.09 | 29967540 | |
320 | Ubiquitination | QLEQITGKGASGTFQ CCEECCCCCCCCCEE | 42.53 | 23000965 | |
323 | Phosphorylation | QITGKGASGTFQLKK ECCCCCCCCCEEECC | 47.21 | 28674419 | |
327 | Ubiquitination | KGASGTFQLKKSGEK CCCCCCEEECCCCCC | 52.81 | 23000965 | |
328 | Ubiquitination | GASGTFQLKKSGEKP CCCCCEEECCCCCCC | 7.06 | 23000965 | |
329 | Ubiquitination | ASGTFQLKKSGEKPL CCCCEEECCCCCCCC | 33.82 | 29967540 | |
358 | Phosphorylation | AAMNEPKTCSTTALK HHHCCCCCCCHHHHH | 23.54 | 24043423 | |
360 | Phosphorylation | MNEPKTCSTTALKKY HCCCCCCCHHHHHHH | 33.74 | 24043423 | |
361 | Phosphorylation | NEPKTCSTTALKKYV CCCCCCCHHHHHHHH | 20.45 | 24043423 | |
362 | Phosphorylation | EPKTCSTTALKKYVL CCCCCCHHHHHHHHH | 17.44 | 24043423 | |
365 | 2-Hydroxyisobutyrylation | TCSTTALKKYVLENH CCCHHHHHHHHHHCC | 39.33 | - | |
365 | Acetylation | TCSTTALKKYVLENH CCCHHHHHHHHHHCC | 39.33 | 25953088 | |
365 | Ubiquitination | TCSTTALKKYVLENH CCCHHHHHHHHHHCC | 39.33 | 23000965 | |
366 | Ubiquitination | CSTTALKKYVLENHP CCHHHHHHHHHHCCC | 41.25 | 23000965 | |
367 | Phosphorylation | STTALKKYVLENHPG CHHHHHHHHHHCCCC | 14.53 | 26356563 | |
375 | Phosphorylation | VLENHPGTNSNYQMH HHHCCCCCCCHHHHH | 39.67 | 28152594 | |
377 | Phosphorylation | ENHPGTNSNYQMHLL HCCCCCCCHHHHHHH | 36.43 | 28152594 | |
379 | Phosphorylation | HPGTNSNYQMHLLKK CCCCCCHHHHHHHHH | 13.66 | 27155012 | |
385 | Acetylation | NYQMHLLKKTLQKCE HHHHHHHHHHHHHHH | 50.50 | 26051181 | |
385 | Ubiquitination | NYQMHLLKKTLQKCE HHHHHHHHHHHHHHH | 50.50 | 29967540 | |
393 | Acetylation | KTLQKCEKNGWMEQI HHHHHHHHCCHHHHH | 70.95 | 26051181 | |
393 | Ubiquitination | KTLQKCEKNGWMEQI HHHHHHHHCCHHHHH | 70.95 | 29967540 | |
403 | Ubiquitination | WMEQISGKGFSGTFQ HHHHHCCCCCCEEEE | 50.41 | - | |
408 | Phosphorylation | SGKGFSGTFQLCFPY CCCCCCEEEEEECCC | 13.65 | 33259812 | |
418 | Phosphorylation | LCFPYYPSPGVLFPK EECCCCCCCCCCCCC | 20.40 | - | |
426 | Ubiquitination | PGVLFPKKEPDDSRD CCCCCCCCCCCCCCC | 74.78 | 24816145 | |
430 | Ubiquitination | FPKKEPDDSRDEDED CCCCCCCCCCCCCCC | 57.18 | 33845483 | |
431 | Phosphorylation | PKKEPDDSRDEDEDE CCCCCCCCCCCCCCC | 49.35 | 30175587 | |
441 | Phosphorylation | EDEDEDESSEEDSED CCCCCCCCCCCCCCC | 56.20 | 28355574 | |
442 | Phosphorylation | DEDEDESSEEDSEDE CCCCCCCCCCCCCCC | 42.85 | 28355574 | |
444 | Ubiquitination | DEDESSEEDSEDEEP CCCCCCCCCCCCCCC | 69.64 | 24816145 | |
446 | Phosphorylation | DESSEEDSEDEEPPP CCCCCCCCCCCCCCC | 50.67 | 28355574 | |
461 | Phosphorylation | KRRLQKKTPAKSPGK CCCCCCCCCCCCCCC | 35.20 | 30576142 | |
464 | Ubiquitination | LQKKTPAKSPGKAAS CCCCCCCCCCCCCHH | 59.39 | 24816145 | |
465 | Phosphorylation | QKKTPAKSPGKAASV CCCCCCCCCCCCHHH | 40.78 | 25849741 | |
468 | Ubiquitination | TPAKSPGKAASVKQR CCCCCCCCCHHHHHC | 44.13 | 33845483 | |
480 | Ubiquitination | KQRGSKPAPKVSAAQ HHCCCCCCCCCCHHH | 21.93 | 24816145 | |
482 | Ubiquitination | RGSKPAPKVSAAQRG CCCCCCCCCCHHHCC | 51.43 | 24816145 | |
508 | Ubiquitination | KAKTPAKKTRPSSTV CCCCCCCCCCCCCEE | 52.45 | 24816145 | |
509 | Phosphorylation | AKTPAKKTRPSSTVI CCCCCCCCCCCCEEE | 47.29 | 29396449 | |
512 | Phosphorylation | PAKKTRPSSTVIKKP CCCCCCCCCEEEECC | 35.04 | 28985074 | |
513 | Phosphorylation | AKKTRPSSTVIKKPS CCCCCCCCEEEECCC | 29.40 | 29970186 | |
514 | Phosphorylation | KKTRPSSTVIKKPSG CCCCCCCEEEECCCC | 30.50 | 29396449 | |
518 | Ubiquitination | PSSTVIKKPSGGSSK CCCEEEECCCCCCCC | 33.04 | 24816145 | |
520 | Phosphorylation | STVIKKPSGGSSKKP CEEEECCCCCCCCCC | 65.74 | 24732914 | |
523 | Phosphorylation | IKKPSGGSSKKPATS EECCCCCCCCCCCCC | 42.37 | 24732914 | |
524 | Phosphorylation | KKPSGGSSKKPATSA ECCCCCCCCCCCCCC | 48.23 | 24732914 | |
529 | Phosphorylation | GSSKKPATSARKEVK CCCCCCCCCCCCCCC | 31.29 | 22817900 | |
530 | Phosphorylation | SSKKPATSARKEVKL CCCCCCCCCCCCCCC | 28.34 | 22817900 | |
533 | Acetylation | KPATSARKEVKLPGK CCCCCCCCCCCCCCC | 67.58 | 26051181 | |
536 | Acetylation | TSARKEVKLPGKGKS CCCCCCCCCCCCCCC | 50.48 | 25953088 | |
544 | Phosphorylation | LPGKGKSTMKKSFRV CCCCCCCCCCHHHCC | 36.17 | - | |
546 | Ubiquitination | GKGKSTMKKSFRVKK CCCCCCCCHHHCCCC | 45.41 | 24816145 | |
548 | Phosphorylation | GKSTMKKSFRVKK-- CCCCCCHHHCCCC-- | 16.87 | 20068230 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HP1B3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HP1B3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HP1B3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-190, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-248 AND SER-249, ANDMASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; SER-442 ANDSER-446, AND MASS SPECTROMETRY. | |
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-132 AND SER-142, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-156, AND MASSSPECTROMETRY. |